Cleared Traditional

K810855 - INTERFACE 20 MICRON TRANSFUSION BLD. F.

K810855 is an FDA 510(k) clearance for INTERFACE 20 MICRON TRANSFUSION BLD. F., manufactured by Abbott Laboratories. The device is a Class 2 Hematology device with product code CAK cleared through the Traditional 510(k) pathway after a 22-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1981
Decision
22d
Days
Class 2
Risk

K810855 is an FDA 510(k) clearance for the INTERFACE 20 MICRON TRANSFUSION BLD. F.. Classified as Microfilter, Blood Transfusion (product code CAK), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on April 21, 1981 after a review of 22 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 880.5440 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K810855

510(k) Number K810855 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 30, 1981
Decision Date April 21, 1981
Days to Decision 22 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
91d faster than avg
Panel avg: 113d · This submission: 22d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAK Device Classification - Class 2, Special Controls

Product Code CAK Microfilter, Blood Transfusion
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - CAK Microfilter, Blood Transfusion

All 19
Devices cleared under the same product code (CAK) and FDA review panel - the closest regulatory comparables to K810855.
PEDIATRIC MICROAGGREGATE BLOOD FILTER
K812874 · Abbott Laboratories · Nov 1981
HEMA 20 MICRON TRANSFUSION BLOOD FILTER
K812697 · Abbott Laboratories · Oct 1981
ULTIPOR SQ40S BLOOD TRANSFUSION FILTER
K811985 · Pall Biomedical Products Co. · Jul 1981
BLOOD FILTER, MICROEMBOLI-ATS-F10
K780145 · Sorensen Research · Feb 1978
FILTER, INFUSION BLOOD (1 PFF-100)
K760165 · Bentley Laboratories, Inc. · Aug 1976
FILTER, TRANSFUSION BLOOD, INTERSEPT
K760222 · Surgikos, Inc. · Aug 1976